Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Esperion Therapeutics Inc (NASDAQ:ESPR)

44.56
Delayed Data
As of Aug 22
 +0.72 / +1.64%
Today’s Change
9.40
Today|||52-Week Range
57.38
+255.91%
Year-to-Date

Today’s Trading

Previous close43.84
Today’s open44.05
Day’s range43.06 - 45.10
Volume822,227
Average volume (3 months)721,115
Market cap$1.1B
Dividend yield--
Data as of 08/22/2017

Growth & Valuation

Earnings growth (last year)-47.35%
Earnings growth (this year)-121.31%
Earnings growth (next 5 years)+1.33%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.40

Competitors

 Today’s
change
Today’s
% change
FWPForward Pharma A/S-0.31-1.27%
GBTGlobal Blood Therape...+0.30+1.12%
BHVNBiohaven Pharmaceuti...+3.17+10.45%
ACORAcorda Therapeutics ...+1.05+4.81%
Data as of 08/22/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$1.83
Annual revenue (last year)$0.00
Annual profit (last year)-$75.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tim M. Mayleben
COO, Executive VP-Research &
Development
Narendra D. Lalwani
Corporate headquarters
Ann Arbor, Michigan

Forecasts